Literature DB >> 2308894

Solid-state chemistry and crystal structure of cefaclor dihydrate.

H Martinez1, S R Byrn, R R Pfeiffer.   

Abstract

Cefaclor [7-(D-2-amino-2-phenylacetamido)-3-chloro-3-cepham-4-carboxy lic acid] crystallizes as the dihydrate. Crystals belong to space group P21, with a = 10.626(3), b = 7.1288(9), c = 14.124(3), and beta = 121.6(2). The structure was solved using direct methods and refined to an R of 0.0535. The bond lengths, angles, and conformation determined are as expected for cephalosporins. The two water molecules are held in the crystal differently. The 13C solid-state NMR spectrum of cefaclor dihydrate is also reported and is consistent with its crystal structure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308894     DOI: 10.1023/a:1015824701581

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

1.  Letter: The effect of crystal packing and defects on desolvation of hydrate crystals of caffeine and L-(--)-1,4-cyclohexadiene-1-alanine.

Authors:  S R Byrn; C T Lin
Journal:  J Am Chem Soc       Date:  1976-06-23       Impact factor: 15.419

2.  Molecular architecture of the cephalosporins. Insights into biological activity based on structural investigations.

Authors:  R M Sweet; L F Dahl
Journal:  J Am Chem Soc       Date:  1970-09-09       Impact factor: 15.419

3.  Crystal pseudopolymorphism of cephaloglycin and cephalexin.

Authors:  R R Pfeiffer; K S Yang; M A Tucker
Journal:  J Pharm Sci       Date:  1970-12       Impact factor: 3.534

4.  The desolvation and oxidation of crystals of dialuric acid monohydrate.

Authors:  R J Clay; A M Knevel; S R Byrn
Journal:  J Pharm Sci       Date:  1982-11       Impact factor: 3.534

  4 in total
  2 in total

Review 1.  Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications.

Authors:  D E Bugay
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

2.  Characterization of three crystalline forms (VIII, XI, and XII) and the amorphous form (V) of delavirdine mesylate using 13C CP/MAS NMR.

Authors:  P Gao
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.